Patents by Inventor Angie Yee

Angie Yee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-MerTK antibodies and methods of use thereof
    Patent number: 11897968
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MerTK polypeptide, e.g., a mammalian MerTK or human MerTK, and use of such compositions in treating an individual in need thereof.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: February 13, 2024
    Assignee: ALECTOR LLC
    Inventors: Seung-Joo Lee, Spencer Liang, Angie Yee, Marina Roell, Arnon Rosenthal
  • ANTI-TMEM106B ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20230303681
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal antibodies, antibody fragments, etc., that specifically bind a TMEM106B polypeptide, e.g., a mammalian TMEM106B or human TMEM106B, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: August 18, 2022
    Publication date: September 28, 2023
    Inventors: Arnon ROSENTHAL, Eric BROWN, Tina SCHWABE, Angie YEE, Herve RHINN
  • ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20230142579
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: August 19, 2022
    Publication date: May 11, 2023
    Inventors: Philip KONG, Herve RHINN, Tina SCHWABE, Angie YEE, Ilaria TASSI, Muhammad Abbas ALHAWAGRI, Arnon ROSENTHAL
  • ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20230126400
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc.. that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: August 19, 2022
    Publication date: April 27, 2023
    Inventors: Philip KONG, Herve RHINN, Tina SCHWABE, Angie YEE, Ilaria TASSI, Muhammad Abbas ALHAWAGRI, Arnon ROSENTHAL
  • ANTI-MS4A6A ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20220380455
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, anti-body fragments, etc., that specifically bind a MS4A6A polypeptide, e g., a mammalian MS4A6A or human MS4A6A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: April 18, 2022
    Publication date: December 1, 2022
    Inventors: Philip KONG, Herve RHINN, Tina SCHWABE, Angie YEE, Arnon ROSENTHAL
  • Anti-MS4A4A antibodies and methods of use thereof
    Patent number: 11472874
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: October 18, 2022
    Assignee: Alector LLC
    Inventors: Philip Kong, Herve Rhinn, Tina Schwabe, Angie Yee, Ilaria Tassi, Muhammad Abbas Alhawagri, Arnon Rosenthal
  • Anti-TMEM106B antibodies and methods of use thereof
    Patent number: 11440957
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal antibodies, antibody fragments, etc., that specifically bind a TMEM106B polypeptide, e.g., a mammalian TMEM106B or human TMEM106B, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: September 13, 2022
    Assignee: ALECTOR LLC
    Inventors: Arnon Rosenthal, Eric Brown, Tina Schwabe, Angie Yee, Herve Rhinn
  • Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof
    Patent number: 11279762
    Abstract: The invention provides anti-idiotypic antibodies against anti-PD-L1 antibodies and methods of using the same.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: March 22, 2022
    Assignee: Genentech, Inc.
    Inventors: Jo-Anne Hongo, Angie Yee, Christine Tan, Joyce Lai, Joanne Adamkewicz, John Byon
  • ANTI-MERTK ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20210261685
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MerTK polypeptide, e.g., a mammalian MerTK or human MerTK, and use of such compositions in treating an individual in need thereof.
    Type: Application
    Filed: December 11, 2020
    Publication date: August 26, 2021
    Inventors: Seung-Joo LEE, Spencer LIANG, Angie YEE, Marina ROELL, Arnon ROSENTHAL
  • ANTI-MS4A6A ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20210122817
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MS4A6A polypeptide, e.g., a mammalian MS4A6A or human MS4A6A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: January 31, 2019
    Publication date: April 29, 2021
    Inventors: Philip KONG, Herve RHINN, Tina SCHWABE, Angie YEE, Arnon ROSENTHAL
  • ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20210040200
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: January 31, 2019
    Publication date: February 11, 2021
    Inventors: Philip KONG, Herve RHINN, Tina SCHWABE, Angie YEE, Ilaria TASSI, Muhammad Abbas ALHAWAGRI, Arnon ROSENTHAL
  • ANTI-TMEM106B ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20200339680
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal antibodies, antibody fragments, etc., that specifically bind a TMEM106B polypeptide, e.g., a mammalian TMEM106B or human TMEM106B, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: December 21, 2018
    Publication date: October 29, 2020
    Inventors: Arnon ROSENTHAL, Eric BROWN, Tina SCHWABE, Angie YEE, Herve RHINN
  • IDIOTYPIC ANTIBODIES AGAINST ANTI-PD-L1 ANTIBODIES AND USES THEREOF
    Publication number: 20190338034
    Abstract: The invention provides anti-idiotypic antibodies against anti-PD-L1 antibodies and methods of using the same.
    Type: Application
    Filed: July 15, 2019
    Publication date: November 7, 2019
    Applicant: Genentech, Inc.
    Inventors: Jo-Anne Hongo, Angie Yee, Christine Tan, Joyce Lai, Joanne Adamkewicz, John Byon